Φορτώνει......
A74 COST-EFFECTIVENESS OF VEDOLIZUMAB COMPARED TO INFLIXIMAB FOR THE MANAGEMENT OF MODERATE-TO-SEVERE ULCERATIVE COLITIS
BACKGROUND: Ulcerative colitis (UC) is a relapsing and remitting condition, characterized by inflammation and ulceration in the colon and rectum. Biologic therapies have shown to be effective in inducing and maintaining remission in patients with UC, however there is no general consensus regarding w...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Can Assoc Gastroenterol |
|---|---|
| Κύριοι συγγραφείς: | , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Oxford University Press
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6508209/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy009.074 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|